SCHEMBL17885202

SCHEMBL17885202

c1ccc(-c2ccc3[nH]c4ccc(-c5cccc6oc7ccccc7c56)cc4c3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ CDK4 P11802 3/20 0.43
▸ CCND1 P24385 3/20 0.43
▸ PLA2G2A P14555 4/20 0.42
▸ PLA2G4A P47712 4/20 0.42
▸ HCRTR1 O43613 1/20 0.40
▸ PLA2G10 O15496 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ CSNK2A2 P19784 1/20 0.40
▸ CSNK2B P67870 1/20 0.40
▸ PIM3 Q86V86 1/20 0.40
▸ PIM2 Q9P1W9 1/20 0.40
▸ ALK Q9UM73 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26055957 0.95 CDK4 (0.41) CASP3SENP7SENP6CDK4CCND1
SCHEMBL26055933 0.93 CASP3 (0.43) CASP3SENP7SENP6CDK4CCND1
SCHEMBL17885210 0.93 CASP3 (0.45) CASP3SENP7SENP6CDK4CCND1
SCHEMBL17885394 0.92 AHR (0.44) CASP3SENP7SENP6CDK4CCND1
SCHEMBL20277322 0.87 PLA2G2A (0.50) CASP3SENP7SENP6PLA2G2APLA2G4A
SCHEMBL25680438 0.85 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL788870 0.85 ALOX5 (0.57) CASP3SENP7SENP6CDK4CCND1
SCHEMBL788745 0.85 ALOX5 (0.57) CASP3SENP7SENP6CDK4CCND1
SCHEMBL25140451 0.84 PLA2G2A (0.46) CASP3SENP7SENP6PLA2G2APLA2G4A
SCHEMBL16745243 0.84 PLA2G2A (0.50) CASP3SENP7SENP6CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237409-B1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2022-01-05 — — EP disclosed
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2019-02-07 — — US disclosed
WO-2016102040-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2016-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS BRD3, BRPF3, DDT CASP3 1113/4885SENP7 3524/4885SENP6 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback